Altimmune Inc (ALT)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Altimmune Inc Faces Financial Setback: Net Loss Deepens in Fourth Quarter of 2023
Altimmune Inc Soars to New Heights: Revenue Surges by 18000% in Q3, 2023
Altimmune Inc Shows Promising Financial Results in Q2 2023 Despite Revenue Decline
Altimmune Inc Faces Challenging First Quarter Performance, Record Decline in Revenue
Evanescence of Losses at the Altimmune Inc in October to December 31 2022 interval
Revenues soared and losess have been cut, at ALT over the second quarter of 2022
Very steep Decline at ALT during the most recent fiscal period
Altimmune Inc reported epic earnings, over the most recent fiscal period